CDK inhibitor Lerociclib, Purity ≥98%

Cat. No.: X24-05-ZQ789

CDK inhibitor Lerociclib, Purity ≥98%

Synonym: 1628256-23-4; G1T-38; G1 T38; G1T38; CDK inhibitor

  • CAS Number: 1628256-23-4
  • Compound CID: 86269224
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Lerociclib, soluble in DMSO and insoluble in ethanol and water, is an CDK kinase inhibitor that disrupts cell division processes. It targets CDK1/cyclinB1, cdk2/cyclin A, CDK2/cyclinE, and Cdk4/cyclin D1.
Molecular Weight
474.613
Molecular Formula
C26H34N8O
Targets
CDK1/cyclinB1: 2.4 μM; cdk2/cyclin A: 1.5 μM; CDK2/cyclinE: 3.6 μM; Cdk4/cyclin D1: 1 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 2 mg/mL (4.21 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Lerociclib can be used to investigate its selective inhibition of CDK4/6 and potential for treating advanced breast cancer.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0